Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

312.00
Delayed Data
As of Aug 27
 +6.02 / +1.97%
Today’s Change
208.64
Today|||52-Week Range
340.34
+21.21%
Year-to-Date

Today’s Trading

Previous close305.98
Today’s open310.00
Day’s range305.49 - 315.00
Volume2,730,510
Average volume (3 months)2,259,860
Market cap$120.4B
Dividend yield--
Data as of 4:01pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+25.23%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.87

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.95+1.93%
NVONovo Nordisk+0.79+1.43%
ABBVAbbVie+1.37+2.17%
BMYBristol-Myers Squibb+0.79+1.32%
Data as of 4:06pm ET, 08/27/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)$4.22
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers